Friday, 20 February 2026 BB Biotech FY 2025 results release   — FY 2025 analyst conference call: 20 February 2026 at 10.00am CET –  [join Webscast]

Friday, 20 February 2026 BB Biotech FY 2025 results release   — FY 2025 analyst conference call: 20 February 2026 at 10.00am CET –  [join Webscast]

Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

INVESTORS

Corporate calendar 

Events 2026
J.P. Morgan 2026 Healthcare Conference
San Francisco (USA)
Monday
January 12, 2026
Baader Swiss Equities Conference 2026
Bad Ragaz (CH)
Wednesday
January 12, 2026
Annual Report 2025
Friday
February 20, 2026
7:00 am
BB Biotech FY 2025 Analyst conference
Friday
February 20, 2026
10:00 am
TD Cowen 4th Annual Healthcare Conference
Boston (USA)
Tuesday
March 3, 2026
Annual General Meeting 2026

Pavillon im Park
Steigstrasse 26
8200 Schaffhausen
Thursday
March 19, 2026
3:00 pm
BB Biotech Dividend 2026 (Proposed)
Ex-dividend date: March 23, 2026
Record date: March 24, 2026
Payment date: March 25, 2026
Interim Report as at March 31, 2026
Friday
April 24, 2026
7:00 am
Interim Report as at June 30, 2026
Friday
July 24, 2026
7:00 am
Interim Report as at September 30, 2026
Friday
October 23, 2026
7:00 am
Rachael Burri
HEAD OF INVESTOR RELATIONS

Rachael Burri

First point of contact for IR enquiries, financial reports, results calendar, share information, or analyst questions.

Office
Bellevue Asset Management AGTheaterstrasse 128001 Zurich, Switzerland